Intelligent Bio Solutions Inc (INBS)
1.64
+0.24
(+17.14%)
USD |
NASDAQ |
Nov 21, 16:00
1.64
0.00 (0.00%)
After-Hours: 06:21
Intelligent Bio Solutions Gross Profit Margin (Quarterly): 39.76% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 39.76% |
| June 30, 2024 | |
| March 31, 2024 | 21.67% |
| December 31, 2023 | 26.08% |
| Date | Value |
|---|---|
| September 30, 2023 | 29.18% |
| June 30, 2023 | 11.19% |
| March 31, 2023 | 7.23% |
| December 31, 2022 | 68.42% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
7.23%
Minimum
Mar 2023
68.42%
Maximum
Dec 2022
29.08%
Average
26.08%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Standard BioTools Inc | 51.73% |
| Ainos Inc | -- |
| Zomedica Corp | 72.32% |
| LENSAR Inc | 46.28% |
| Adagio Medical Holdings Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -176.4% |
| Return on Assets | -86.71% |
| Return on Invested Capital | -161.2% |
| Profit Margin (Quarterly) | -307.9% |
| Operating Margin (Quarterly) | -312.4% |
| Return on Net Operating Assets | -89.59% |